3T Biosciences
South San Francisco, US · Founded 2017 · 6 known investors
3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
AI & Machine LearningBiotechHealthtechMedical Devices
Founders & leadership
3T Biosciences was founded in 2017 by K. Christopher Garcia and Marvin Gee.
KC
K. Christopher Garcia
MG
Marvin GeeinChief Research Officer, Co-Founder
Investors · 6
Competitors · 2
by search overlap
Third Arc Bio11 shared keywordsThird Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering. The company is led by a team with a track record of 35+ drug approvals.
3Bar Biologics10 shared keywords
Companies competing with 3T Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does 3T Biosciences do?
- 3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
- Who founded 3T Biosciences?
- 3T Biosciences was founded by K. Christopher Garcia, Marvin Gee in 2017.
- Who are 3T Biosciences's investors?
- 3T Biosciences's investors include Asset Management Company, CRV (Charles River Ventures), Westlake Village BioPartners, Menlo Ventures, OS Fund, Starlight Ventures.
- Where is 3T Biosciences headquartered?
- 3T Biosciences is headquartered in South San Francisco, US.